IL6 and cancer: Moreover, building mouse cancer models, or tissue-engineered 3D models, that more accurately model the effects of targeting IL-6 in the human should lead to better clinical results in the future and avoid the pitfalls of wasted time and money on unsuccessful clinical trials.